London-headquartered healthcare
company, which has served over 20 Lakh patients globally, launches Voy India to
make evidence-based obesity treatment accessible nationwide
New Delhi, India : Voy, the London-headquartered digital healthcare company and market
leader in GLP-1 obesity care in the UK, Germany, and Brazil, today announced
its entry into India through the 100% acquisition of EarlyFit, one of India’s
leading online weight loss platforms.
Voy is emerging as a global multi-country
leader in preventive healthcare, especially GLP-1-led weight loss. Voy entered
Germany through the acquisition of Formel Skin ($40M raised) and has also
acquired Morelife, Menopause Care, Optimale, and now EarlyFit.
This acquisition marks Voy’s entry into one
of the world’s largest and fastest-growing healthcare markets with the goal to
serve 150M obese Indians. This brings Voy’s global clinical expertise,
research, and technology to India, making this the first international D2C
Health player to enter India.
Voy India will continue to serve patients
across the country through a network of more than 20 endocrinologists and
nutritionists, led by Dr. Saptarshi Bhattacharya (DM Endocrinology,
AIIMS), along with EarlyFit co-founders Parth Chopra and Saloni Paliwal. Voy
India will initially focus on weight loss and obesity care, leading with
affordable generic semaglutide offerings that became more accessible after
Ozempic’s patent expired in India in March 2026. while gradually expanding into
broader therapeutic areas using Voy’s global clinical expertise. Eventually,
they’re expected to launch hair loss, dermatology, menopause, hormone, and
testosterone replacement therapy, bringing learnings from global markets to
India.
George Pallis, Founder and CEO of Voy,
added, “We are incredibly excited to
welcome the Early Fit team to Voy. This acquisition marks our entry into the
most populous country globally, a really meaningful step towards building Voy
into a truly global platform. It has been wonderful to see what Parth Chopra
and Saloni Paliwal have built in the short time since they founded the business
and to see the alignment in underlying values of patient centricity and quality
of care.”
Saloni Paliwal, co-founder of EarlyFit,
now Voy India, added, “Through this
partnership, we are bringing world-class obesity treatment to India at a
pivotal moment when awareness is rising and access is expanding rapidly. By
combining global expertise, advanced technology, and clinically proven systems,
we are proud to launch India’s most trusted and safety-first platform for
obesity care.”
In a peer-reviewed study involving more
than 125,000 patients, Voy users achieved an average of 24% weight loss over 12
months, compared with 19% with medication alone. Ninety percent of patients
reached their self-defined health goals while maintaining a market-leading
clinical incident rate of less than 0.2%, significantly lower than the
approximately 4% seen in standard care. University of Cambridge, Harvard
University, Imperial College London, and UCL have shown that Voy’s integrated
care model delivers superior outcomes.
About Voy:
Founded in 2018, Voy is redefining how
healthcare is delivered and accessed globally. With a strong presence in the
UK, Brazil, and Germany, Voy has already served over 2 million patients
globally. The company combines market leading clinical quality and safety,
behavioural support, and ongoing care into a single, seamless experience. Voy
helps people to address some of the most life-impacting conditions, from
obesity and hormonal health to hair loss and menopause, as well as preventative
care through its Do Health offering.
About Voy India (formerly EarlyFit)
Voy India (formerly EarlyFit) is a digital
obesity and weight management platform serving patients nationwide through a
network of specialist endocrinologists and clinicians. The platform provides
evidence-based treatment plans, including GLP-1 therapies where clinically
appropriate, combined with ongoing medical supervision and behavioural support.